Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the treatment outcomes of preoperative versus postoperative concurrent chemoradiotherapy (CRT) on locally advanced rectal cancer.
Materials and Methods: Medical data of 114 patients with locally advanced rectal cancer treated with CRT preoperatively (54 patients) or postoperatively (60 patients) from June 2003 to April 2011 was analyzed retrospectively. 5-Fluorouracil (5-FU) or a precursor of 5-FU-based concurrent CRT (median, 50.4 Gy) and total mesorectal excision were conducted for all patients. The median follow-up duration was 43 months (range, 16 to 118 months). The primary end point was disease-free survival (DFS). The secondary end points were overall survival (OS), locoregional control, toxicity, and sphincter preservation rate.
Results: The 5-year DFS rate was 72.1% and 48.6% for the preoperative and postoperative CRT group, respectively (p = 0.05, the univariate analysis; p = 0.10, the multivariate analysis). The 5-year OS rate was not significantly different between the groups (76.2% vs. 69.0%, p = 0.23). The 5-year locoregional control rate was 85.2% and 84.7% for the preoperative and postoperative CRT groups (p = 0.98). The sphincter preservation rate of low-lying tumor showed significant difference between both groups (58.1% vs. 25.0%, p = 0.02). Pathologic tumor and nodal down-classification occurred after the preoperative CRT (53.7% and 77.8%, both p < 0.001). Acute and chronic toxicities were not significantly different between both groups (p=0.10 and p = 0.62, respectively).
Conclusion: The results confirm that preoperative CRT can be advantageous for improving down-classification rate and the sphincter preservation rate of low-lying tumor in rectal cancer.

참고문헌 (Reference)

1 송진호, "직장암의 수술 전 항암화학방사선치료 후 병리학 및 임상적 효과 분석" 대한방사선종양학회 29 (29): 11-19, 2011

2 윤미선, "직장암의 수술 전 동시적 항암화학방사선치료 결과" 대한방사선종양학회 26 (26): 247-256, 2008

3 Janjan NA, "Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M. D. Anderson Cancer Center experience" 44 : 1027-1038, 1999

4 Douglass HO Jr, "Survival after postoperative combination treatment of rectal cancer" 315 : 1294-1295, 1986

5 Minsky BD, "Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer" 13 : 1409-1416, 1995

6 Lee JH, "Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report" 20 : 1751-1758, 2002

7 Park JH, "Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer" 117 : 3703-3712, 2011

8 Gastrointestinal Tumor Study Group, "Prolongation of the disease-free interval in surgically treated rectal carcinoma" 312 : 1465-1472, 1985

9 Capirci C, "Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients" 72 : 99-107, 2008

10 Rodel C, "Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer" 23 : 8688-8696, 2005

11 Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer" 351 : 1731-1740, 2004

12 Roh MS, "Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03" 27 : 5124-5130, 2009

13 Lee JH, "Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes" 81 : 431-438, 2011

14 Fisher B, "Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: result from NSABP R-01" 80 : 21-29, 1988

15 Ruo L, "Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy" 236 : 75-81, 2002

16 Janjan NA, "Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer" 24 : 107-112, 2001

17 Rullier A, "Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma" 34 : 562-568, 2010

18 Rosenberg R, "Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival" 97 : 8-13, 2008

19 Krook JE, "Effective surgical adjuvant therapy for high-risk rectal carcinoma" 324 : 709-715, 1991

20 Chen ET, "Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation" 30 : 169-175, 1994

21 Gerard JP, "Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2" 28 : 1638-1644, 2010

22 Park IJ, "Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy" 56 : 135-141, 2013

23 Gerard JP, "Clinical outcome of the ACCORD 12/0405 Prodige 2 randomized trial in rectal cancer" 30 : 4558-4565, 2012

24 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009" 대한암학회 44 (44): 11-24, 2012

25 Choy H, "Basic concepts of chemotherapy and irradiation interaction, In Perez and Brady's principles and practice of radiation oncology" Lippincott Williams & Wilkins 672-673, 2008